KGA Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of KGA Antibodies for research applications. KGA Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KGA, or kidney-specific glutaminase, plays a crucial role in the metabolism of glutamine, converting it into glutamate, which is essential for cellular energy production and nitrogen metabolism. KGA is particularly active in kidney function and has significant implications in various metabolic disorders. Research focusing on KGA can advance understanding of kidney health and disease mechanisms. Scientists studying KGA can uncover new pathways in metabolic regulation and potential therapeutic targets. Investigating KGA expression patterns helps reveal its role in different physiological states. KGA research contributes to developing new approaches for treating kidney-related conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of kidney function and metabolic processes.